Verivalikoiman

Verivalikoima refers to the set of blood and blood-derived products that a hospital transfusion service or blood bank keeps available for clinical use. The collection typically includes cellular components such as red blood cell concentrates, platelets, and, where applicable, white cell–containing products; plasma and plasma-derived products such as fresh frozen plasma and cryoprecipitate; and, in some systems, stem cell products or granulocyte concentrates. Depending on the facility, the verivalikoima may also cover related supplies and reagents used in testing, crossmatching, and component preparation.

Purpose and scope

The verivalikoima supports safe, timely transfusion practice and overall patient blood management. It is shaped by clinical demand, patient demographics, and regulatory requirements. Inventory management aims to ensure adequate stock for routine and emergency needs while minimizing waste through shelf-life control and efficient rotation of products.

Storage, handling and safety

Different components require specific storage conditions and handling procedures. Red blood cells are stored refrigerated, platelets at room temperature with agitation, and plasma or cryoprecipitate frozen. Strict traceability, accurate labeling, and documentation are essential, as is adherence to quality assurance, regular supplier audits, and incident reporting. Safety measures include donor screening and infectious disease testing in line with national and international guidelines.

Regulatory framework

Verivalikoima management is governed by national health authorities and international standards, such as EU directives and WHO guidelines, ensuring product quality, traceability, and patient safety. Collaboration among transfusion services, procurement, and clinical departments is central to maintaining an effective and compliant blood product assortment.

See also

Transfusion medicine, Blood bank, Patient blood management, Blood products.